Overview
Availability
- Associate Professor John Cole is:
- Available for supervision
Works
Search Professor John Cole’s works on UQ eSpace
2022
Journal Article
Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience
Levy, Julia, Farag, Fady and Cole, John (2022). Factors influencing the initiation of adjuvant endocrine therapy in patients with estrogen receptor-positive ductal carcinoma in situ: a single institution experience. Breast Cancer Research and Treatment, 196 (1), 207-213. doi: 10.1007/s10549-022-06735-9
2017
Journal Article
Endocrine therapy for early breast cancer: Updated review
Tremont, Alexander, Lu, Jonathan and Cole, John T. (2017). Endocrine therapy for early breast cancer: Updated review. Ochsner Journal, 17 (4), 405-411. doi: 10.1043/TOJ-17-0036
2015
Journal Article
Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathy
Jahangir, Eiman, Shah, Sangeeta, Shum, Kelly, Baxter, Caitlin, Fitzpatrick, Jill D., Cole, John, Gilliland, Yvonne and Polin, Nichole M. (2015). Risk assessment and management of anthracycline and HER2 receptor inhibitor-induced cardiomyopathy. Southern Medical Journal, 108 (2), 71-78. doi: 10.14423/SMJ.0000000000000232
2013
Journal Article
Cancer stem cell and stromal microenvironment
Li, Li, Cole, John and Margolin, David A. (2013). Cancer stem cell and stromal microenvironment. Ochsner Journal, 13 (1), 109-118.
2012
Journal Article
A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential
Lee, Chung-Gi, Das, Bikul, Lin, Tara L., Grimes, Chelsea, Zhang, Xin, Lavezzi, Tracey, Huang, Li, Cole, John, Yau, Lillian and Li, Li (2012). A rare fraction of drug-resistant follicular lymphoma cancer stem cells interacts with follicular dendritic cells to maintain tumourigenic potential. British Journal of Haematology, 158 (1), 79-90. doi: 10.1111/j.1365-2141.2012.09123.x
2012
Conference Publication
L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemia
Ramos, Ofelia Crombet, Hernandez, Claudia, Morrow, Kevin, Cole, John T. and Rodriguez, Paulo (2012). L-arginine depletion by PEG-arginase I, a new potential therapy for acute lymphoblastic leukemia. 48th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO), Chicago Il, Jun 01-06, 2012. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY.
2011
Conference Publication
B12 DEFICIENCY REVISITED
Jahangir, K. S., Varughese, S., Lin, T. L., Boulmay, B. C., Rigby, P. G. and Cole, J. T. (2011). B12 DEFICIENCY REVISITED. Southern Regional Meeting, New Orleans La, Feb 17-19, 2011. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2011
Conference Publication
MY COLLAR BONE HURTS!
Varughese, S., Jahangir, K. S., Lin, T., Boulmay, B., Rigby, P. and Cole, J. T. (2011). MY COLLAR BONE HURTS!. Southern Regional Meeting, New Orleans La, Feb 17-19, 2011. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS.
2010
Journal Article
Pegylated arginase I: a potential therapeutic approach in T-ALL
Hernandez, Claudia P., Morrow, Kevin, Lopez-Barcons, Lluis A., Zabaleta, Jovanny, Sierra, Rosa, Velasco, Cruz, Cole, John and Rodriguez, Paulo C. (2010). Pegylated arginase I: a potential therapeutic approach in T-ALL. Blood, 115 (25), 5214-5221. doi: 10.1182/blood-2009-12-258822
2009
Conference Publication
Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL)
Velcheti, Vamsidhar, Li, Li, Philips, Joseph, Fuloria, Jyotsna, Rodwig, Francis R., Cole, John T., Samaniego, Felipe and Prakash, Om (2009). Prelinical Evaluation of Lyn Kinase Inhibition for the Treatment of B Cell Chronic Lymphocytic Leukemia (B-CLL). 51st Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 05-08, 2009. WASHINGTON: AMER SOC HEMATOLOGY.
2008
Conference Publication
Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia Cells
Velcheti, Vamsidhar, Tamma, Srikanth, Larned, Zoe L., Fuloria, Jyotsna, Li, Li, Rodwig, Francis R., Cole, John T., Samaniego, Felipe and Prakash, Om (2008). Protein Kinase C-Epsilon Is An Important Component of the Lyn Kinase Signaling Pathway in the Apoptotic Resistance of B-Chronic Lymphocytic Leukemia Cells. 50th Annual Meeting of the American-Society-of-Hematology, San Francisco Ca, Dec 06-09, 2008. WASHINGTON: AMER SOC HEMATOLOGY.
2008
Conference Publication
Differences in treatment and outcomes of non-small cell lung cancer (NSCLC) in Louisiana compared to the rest of the United States: A National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) analysis
Velcheti, V., Thumma, V., Matrana, M. and Cole, J. T. (2008). Differences in treatment and outcomes of non-small cell lung cancer (NSCLC) in Louisiana compared to the rest of the United States: A National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) analysis. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. doi: 10.1200/jco.2008.26.15_suppl.17507
2007
Journal Article
Chicken Sarcoma to Human Cancers: A Lesson in Molecular Therapeutics
Prakash, Om, Bardot, Stephen F. and Cole, John T. (2007). Chicken Sarcoma to Human Cancers: A Lesson in Molecular Therapeutics. Ochsner Journal, 7 (2), 61-64.
2005
Journal Article
A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932
Perez, Edith A., Suman, Vera J., Fitch, Tom R., Mailliard, James A., Ingle, James N., Cole, John T., Veeder, Michael H., Flynn, Patrick J., Walsh, Daniel J. and Addo, Ferdinand K. (2005). A phase II trial of docetaxel and carboplatin as first-line chemotherapy for metastatic breast cancer: NCCTG study N9932. Oncology, 69 (2), 117-121. doi: 10.1159/000087813
2004
Journal Article
Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer
Le Chevalier, T., Arriagada, R., Le Pechoux, C., Grunenwald, D., Dunant, A., Pignon, J. P., Tarayre, M., Abratt, R., Arriagada, R., Bergman, B., Gralla, R., Grunenwald, D., Le Chevalier, T., Orlowski, T., Papadakis, E., Pinel, M. I. Sathler, Araujo, C., Della Torre, H., de Solchaga, M. Masetto, Abdi, E., Blum, R., Ball, D., Basser, R., De Boer, R., Bishop, J., Brigham, B., Davis, S., Fox, D., Richardson, G. ... Wedel, H. (2004). Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. New England Journal of Medicine, 350 (4), 351-360. doi: 10.1056/NEJMoa031644
2001
Journal Article
A Phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade glioma
Buckner, J. C., Schomberg, P. J., McGinnis, W. L., Cascino, T. L., Scheithauer, B. W., O'Fallon, J. R., Morton, R. F., Kuross, S. A., Mailliard, J. A., Hatfield, A. K., Cole, J. T., Steen, P. D. and Bernath, A. M. (2001). A Phase III study of radiation therapy plus carmustine with or without recombinant interferon-α in the treatment of patients with newly diagnosed high-grade glioma. Cancer, 92 (2), 420-433. doi: 10.1002/1097-0142(20010715)92:23.0.CO;2-3
1995
Journal Article
Sepsis due to coryneform group A-4 in an immunocompromised host
Bizette, G. A., Kemmerly, S. A., Cole, J. T., Bradford, H. B. and Peltier, B. H. (1995). Sepsis due to coryneform group A-4 in an immunocompromised host. Clinical Infectious Diseases, 21 (5), 1334-1336. doi: 10.1093/clinids/21.5.1334
1993
Journal Article
SPLENECTOMY IN THE HIV-INFECTED PATIENT - REPLY
COLE, JT and FLAUM, MA (1993). SPLENECTOMY IN THE HIV-INFECTED PATIENT - REPLY. Southern Medical Journal, 86 (8), 980-980. doi: 10.1097/00007611-199308000-00032
1992
Journal Article
Postsplenectomy infections
Cole, J. T. and Flaum, M. A. (1992). Postsplenectomy infections. Southern Medical Journal, 85 (12), 1220-1226. doi: 10.1097/00007611-199212000-00014
1991
Journal Article
A Phase I study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancer
Bhalla, K., Birkhofer, M., Bhalla, M., Lutzky, J., Hindenburg, A., Cole, J. and Ince, C. (1991). A Phase I study of a combination of allopurinol, 5-fluorouracil and leucovorin followed by hydroxyurea in patients with advanced gastrointestinal and breast cancer. American Journal of Clinical Oncology - Cancer Clinical Trials, 14 (6), 509-513. doi: 10.1097/00000421-199112000-00009
Supervision
Availability
- Associate Professor John Cole is:
- Available for supervision
Looking for a supervisor? Read our advice on how to choose a supervisor.
Media
Enquiries
For media enquiries about Associate Professor John Cole's areas of expertise, story ideas and help finding experts, contact our Media team: